Transcutaneous Auricular Vagus Nerve Stimulation Treatment for Rosacea: A Pilot Trial
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
A single arm, pilot study among individuals with rosacea and at least moderate flushing or rednesss will be enrolled in a 4-week trial of taVNS. The particicpants will be followed for an additional 4-weeks following the intervention period to evaluate the durability of the results
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Adults aged 18 years of age and older
• Dermatologist confirmed diagnosis of rosacea
• Clinician's Erythema Assessment of at least 3 (moderate to severe disease)
• Willingness to adhere to current rosacea regimen without additions or laser treatments (e.g. PDL) during the study period.
Locations
United States
Massachusetts
Brigham and Women's Hospital
RECRUITING
Boston
Contact Information
Primary
Liset Chacin
lchacin@bwh.harvard.edu
617-264-5926
Time Frame
Start Date: 2026-05-23
Estimated Completion Date: 2028-02-28
Participants
Target number of participants: 10
Treatments
Experimental: Rosacea
Related Therapeutic Areas
Sponsors
Leads: Brigham and Women's Hospital